Mr. Schmidt is a managing director - partner and global co-head of healthcare at Carlyle. Since joining Carlyle in 2011, Mr. Schmidt has been involved in a number of the firm’s investments globally, including Beats Electronics, Included Health (formerly Grand Rounds), Medline, MedRisk, One Medical, QuidelOrtho (formerly Ortho Clinical Diagnostics), Resonetics, Sedgwick, Unchained Labs, and Vantive. He is currently also a member of the board of directors of Included Health, Medline, MedRisk, Resonetics, and Unchained Labs. Prior to joining Carlyle, Mr. Schmidt worked at Welsh, Carson, Anderson & Stowe, a private equity firm focused on healthcare and technology investments, and Merrill Lynch Global Private Equity, where he focused on buyouts in North America.
Mr. Schmidt received his MBA from Harvard Business School and a Bachelor of Science in Economics from The Wharton School at the University of Pennsylvania, where he is currently a member of the External Advisory Board at the Leonard Davis Institute of Health Economics.
Asia Pacific
